INTRODUCTION
Many people spend a large proportion oftheir lives working and many of these workers are continuously exposed to a variety of hazards broadly categorized as physical, biological, and chemical Application of epidemiologic methods in the study of occupational hazards and diseases has proliferated in an effort to better understand factors which may be associated with disease causation in at-risk workers. Recent investigations have explored the possibility that the handling of antineoplastic agents may be associated with potential health hazards Many nurses working in hospitals, oncology clinics, and private oncologists' offices are exposed to antineoplastic agents on a regular basis through preparation and administration of these agents. Handling these agents may result in systemic absorption via inhalation, skin contact with the agent, and ingestion. Many antineoplastic agents themselves are carcinogenic and mutagenic, and, in relation to workers who handle these agents, should be considered potentially hazardous substances.
As a group, health care workers have been an underscrutinized working population who are subject to many unhealthy exposures. More than 65% of the employees who work in this industry are women and many are women who are in childbearing years Data from the Bureau of Labor Statistics (1982) Indicate that women constitute more than 40% of the civilian labor force and approximately 20 million, nearly half, are women between the ages of 18 to 24 years of age In addition, the March of Dimes (Personal Communications, 1984) reports that the number of births to women over 35 years of age has increased dramatically (46%) during the last decade.
Women comprise approximately 96% of the nursing profession. There are more than one million registered nurses In the United States who are actively practicing (Bureau of Health Professionals, 1983) It IS difficult to determine the number of nurses who handle the antineoplastic agents; however, it has been estimated that approximately 20,000 nurses may be engaged in the practice of oncology Health care workers have been an underscrutinized working population who are subject to many unhealthy exposures.
nursing. These nurses work In a variety of settings including hospitals, clinics, cancer treatment centers, and private oncologists' offices. It is probably safe to assume that many of these nurses are In childbearing years. This, of course, does not Include other workers who come into contact with these agents, such as pharrnecrsts, physicians, and housekeeping personnel.
Antineoplastic agents are themselves potentially hazardous substances. Workers who handle these agents may be at risk of developing acute and long-term health problems Many of these workers are women in childbearing ages or may be pregnant and subject to adverse exposures With the potential of fetal insult. Therefore, it is important to understand the action and toxic effects of these agents and to recognize measures to reduce worker exposure.
ANTINEOPLASTIC AGENTS
The discovery of nitrogen mustard In the 1940s led to the use of chemotherapy for treatment of cancer The purpose of chemotherapy treatment is to destroy cancer cells and spare normal cells Antineoplastic agents kill or Impair susceptible tumor cells by blocking a drugsensitive biochemical pathway Many of these drugs have cell cycle specific cytotoxicity and target their action spe-Cifically at processes such as DNA syn-
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CLASSIFICATION OF CHEMOTHERAPEUTIC TOXICITY
thesis, mitosis, or at resting cells Other drugs such as alkylatlng agents are phase non-specific and are cytotoxic for cells at any point in the cycle (Goodman & Gilman, 1984; Reich, 1981) In general, anti-cancer drugs can be divided into two principal groups by mechanism of action:
• those that interact directly with DNA to alter the template for DNA replication or RNA transcription; and • those that inhibit nucleic acid synthesis by blocking the pathways for purine and pyrimidine nucleotide formation (Holland & Frei, 1982; Weisberger et ai, 1975) Although antineoplastic agents interfere with tumor cell replication, normal body cells and normal marrow stem cells are also vulnerable to attack and subject to damage, mutation, or killing. The utility of the antineoplastic agents depends on the therapeutic to toxic ratio. The Side effects of these agents may be very severe and may depend on a variety of host factors Including age, nutrition and pre-existing disease. Perry (1982) has classified Side effects of chemotherapeutic agents as immediate (occurring within the first 24 hours), early (occurring Within days to weeks), delayed (occurring Within weeks to months), and late (occurring within months to years) These are shown In Table 1 We are qurte familiar with Immediate and early effects and less knowledgeable about delayed and late effects.
The anti-cancer drugs can be divided Into non-hormonal and hormonal agents The classification and type of agents within these groupings along With their tOXIC effects are shown In Gillman, 1984; Greenwald, 1973; Holland & Frei, 1982) The antimetabolic agents comprise the folic acid antagonists and the purine and pyrrmidine analogs Folic acid is an essential dietary factor which IS the starting pomt of a serres of biochemical processes, each of which results In a metabolite essential for purine synthesis and the recovery of folic acid The folate antagonists interfere With one or more of these biosynthetic steps Involving folate co-enzymes of the tumor cell (Goodman & Gilman, 1984; Greenwald, 1973; Hoiland & Frei, 1982) ing with nucleic acid formation, specifically through Inhibition and regulation of enzymes which serve to control purine biosynthesis. This results in functionally altered nucleotides and cell cycle disruption. Newer purine analogs, such as arabinosyladenine, function in a similar manner by interfering with DNA synthesis through inhibition of DNA polymerase (Boeson & Davis, 1969; Carter, Bakowski, & Hellman, 1981; Goodman & Gilman, 1984; Holland & Frei, 1982) The pyrimidine analogs represent another group of compounds whose side chain structure has been altered by substitution, for example, with a halogenated pyrimidine, fluorouracil. Fluorouracil then becomes Incorporated into RNA (In place of urecil). Fluorouracil IS ultimately converted to a growth inhibitor that acts to suppress necessary enzymes which are essential for DNA synthesis Cytosine arabinoside (Ara-C), exerts its action through Incorporation into DNA and RNA Ara-C inhibits DNA and less specifically RNA polymerase The pyrimidine analog exerts its lethal effect only on dividing cells (Carter, Bakowski, & Hellman, 1981; Greenwald, 1973; Heidelberger, 1977; Holland & Frei, 1982) The value of the use of natural products in the treatment of various diseases has long been established through folklore and tradition. vinblesine and vincristine, the most extensively used vinca alkaloids, are derived from the periwinkle plant. Plant alkaloids interfere with normal mitosis. The mechanism of action of these agents is not clearly understood. It is thought that these agents bind specifically with cell protein thereby disrupting cellular functions and ultimately resulting In cell death (Carter, Bakowski, & Hellman, 1981; Greenwald, 1973; Holland & Frei, 1982) For several years antibiotics have been tested for possible antitumor activities and several have been found to exert cytOtOXIC and antineoplastic effects In general, antibiotics act on both normal and neoplastic cells by interfering with cellular and nucleic acid processes However, the mechanism of action of each agent is targeted to a specific molecule or site within the genetic structure and/or cell cycle phase The more commonly used anti-tumor antibiotics will be briefly discussed Daunorubicin and doxorubicin are anthracyclines whose entineoplestic action is not yet fUlly understood; however, they appear to act to inhibit DNA transcription and duplication processes (Carter, Bakowski, & Hellman, 1981; DeMars & Jackson, 1977; Greenwald, 1973; Holland & Frei, 1982) .
CLASSIFICATION OF ANTINEOPLASTIC AGE~tTS AND THEIR TOXIC EFFECTS
Bleomycin is an amino acid antibiotic that binds and reacts With DNA ceusing single strand scission and fragmentation of the DNA molecules Knowledge of the mechanism of action of Actinomycin D is limited Its biological effect IS due to binding with DNA, at extremely low concentrations, leading to Inhibition of DNA dependent RNA synthesis and Greenwald, 1973; Holland & Frei, 1982) The enzyme L-asparaginase (Elspar) was initially believed to be the biochemical agent that was cytotoxic to malignant cells while sparing normal cells. This enzyme catalyzes the hydrolysis of asparaginase and deprives malignant ceils of an essential amino acid. This deprivation causes rapid inhibition of protein synthesis and cell death Although normal tissues synthesize their own L-asparaginase, evidence now exists which indicates that several functions of some normal tissues are sensitive to this enzyme treatment (Carter, Bakowski, & Hellman, 1981; Greenwald, 1973; Holland & Frei, 1982) .
COMPARISON OF IN VITRO AND EXPERIMENTAL TESTING OF ANTINEOPLASTIC AGENTS
There are a variety of miscellaneous or synthetic agents which are used for their antineoplastic activity These include such agents as dacarbazine and procarbazine which have both alkylating and antimetabolic properties and hexamethylmelamine which acts as a pyrimidine analog (Carter, Bakowski, & Hellman, 1981; Greenwald, 1973; Hoiland & Frel, 1982) The platinum compounds act like alkylating agents (Carter, Bakowski, & Hellman, 1981; Greenwald, 1973; Holland & Frci, 1982) There are a number of experimental drugs used in antineoplastic therapy whose mechanisms of action are stili under investigation. These drugs can be found In Table   2 .
It has long been recognized that some human cancers are Influenced by fluctuations In the levels of steroid sex hormones through alteration of the hormonal milieu All of the steroidal hormones, estrogens, progestogens, and androgens have a Similar cellular mechanism of action The steroid hormones cross cell membranes by simple diffusion and bind to protein receptor molecules which are transferred into the cell nucleus In close apposition to the chromatin. MetaboliC alterations ensue and there IS a rapid synthesis of mRNA and unknown proteins. Enzymes and necessary proteins are manufactured that carry out the specific cellular function of the hormone Antineoplest«; agents are cytOtOXIC
PROBLEMS OR RISK FACTORS ASSOCIATED WITH HANDLING ANTINEOPLASTIC AGENTS
• Personnel are frequently unaware of potential hazards.
• Few people handle these drugs regularly.
• Exposure to other hazardous substances may exist.
• Certain groups may have greater exposure.
• Environment may contribute to risk of exposure.
• Procedures for handling agents vary.
• Protective measures are used inconsistently.
@Wi survival of patients with cancer due to increased knowledge about the natural history of certain cancers and aggressive treatment with radiotherapy and chemotherapy Concurrently, there has been increased exposure to these potential hazards to health care workers through the handling of antineoplastic agents (Rubadue, 1985) Problems or risk factors for personnel who handle the antineoplastic agents are identified in Table   4 . Individuals who prepare or administer the drug are not always aware of the potential hazards related to exposure through inhalation, skin contact, and less frequently through ingestion Most often, it is the oncology nursing personnel or pharmacist who is exposed thereby increasing the risk of exposure to a small group of people. This includes staff working in hospitals, clinics, and private offices Other chemical or hazardous exposures in the work environment may be present. In addition, passive or selfinduced exposure to cigarette smoke may cause an additive risk. Procedures for self-protection and safe handling of these agents vary considerably from institution to institution, and gUidelines which describe practices for handling and disposing of contaminated rnetcriels are not always observed. Neal et al (1983) through ambient air sampling, detected both fluourouracil and cyclophosphamide in outpatient clinics These Investigators, along with valenis and Browne (1985) and Stellman et al (1982) , have reported on the lack of use of personal protective measures Crudi (1980) and Ladik et al (1980) have reported on a variety of somatic J complaints from personnel handling antineoplastic agents including headache, nausea, dizziness, nasal sores, and light-headedness Wilson (1981) , In contrast, reported no unusual symptoms in oberrrecists who prepared antineoplastic agents Epidemiologic studies of hazards to nurses and pharmacists who prepare and/or administer these agents have resulted m conflicting and Inconclusive data; however, urine mutagenicity, unne drug excretion and increased levels of chromosome aberrations are apparent Jagun et al (1982) and Hirst et el (1984) have reported the excretion of cyclophosphamide in the urine of nurses who handled this drug Anderson et el. (1982) In a prospectrve study, examined urine of exposed and unexposed pharmacists for several elghtday periods and found that exposed subjects exhibited a much higher rate of urinary mutagenicity when compared to unexposed subjects Falck et el. (1979) found statistically Significant differences In the frequency of urinary mutagens in samples of urine from nurses who handled the antineoplastiC agents when compared to unexposed psychologists and clerical workers Rogers (1986) compared 59 nurses working in hospitals, oncology clinics, and private oncologists' offices With an unexposed group of 64 community health nurses Exposed non-smoking nurses had a Significantly greater proportion of POSitive urinary mutagenicity than did the unexposed group Nurses in oncology clinics and private phvsiciens' offices were at greater nsk of excreting mutagenic unne Several recent studies sup-port these findings (Bos, 1982; Kolmodin-Hcdrnsn et ai, 1983; Nguyen et ai, 1982; Stucker, et a!, 1986) Conflicting reports by Hoffman (1983) , who conducted mutation assays on unne of nurses who only administered these agents, and verutt (1984), who conducted Similar assays on the urine of nurses and ohermecists who were heav-Ily gloved and masked, show no statistically Significant differences A recent study by Gibson et al (1984) supports these findings Cytogenic studies by Norppa et al (1980) and Waksvic et el. (1981) indicated statistically significant increases in the frequency of sister chromatid exchanges In nurses who handled chemotherapeutic substances. This conflicts with the findings of Stiller et el. (1983) and Stucker et el. (1986) Laslla et el. (1980) found no difference between exposed and unexposed subjects With respect to Immunoglobulin markers. Selevan et al (1985) recently reported an increased number of spontaneous abortions related to occasional exposure to antineoplastic agents Sotanierni et el (1983) published a report on diagnosed liver damage to nurses who had handled cytotoxic drugs for a number of years Factors such as smoking, alcohol, diet, and medication Intake need to be considercd when Interpreting the results of the mutagen assays, such as the Ames assay, as these factors may influence the results of the test and need to be controlled for in the study design (Bos et ai, 1983; Bruce et el., 1977; Connor et ai, 1983; Gelbart & Sontag, 1980; Lang & Redmann, 1979; Nagao et ai, 1977; Nagao et ai, 1981; Yamasaki & Ames, 1977) 
HANDLING PRACTICES
The primary routes of exposure dunng the preparation and administration of antineoplastiC agents are through inhaletion of the aerosolized drug, direct skin contact, and less often through Ingestion. The risks to personnel who handle these agents are a result of the level and duration of exposure to these tOXIC agents while at work Numerous gUidelines for safe handling of these agents have been published in recent years (Council on SCIentifiC Affairs, 1985; HIIIcoat et el.. 1983; Oncology NurSing Society, 1984; US Department of Labor, 1986; Vaughn & Chnstensen, 1985) ; however, evidence cxrsts that personnel who prepare and administer these drugs Inconsistently observe safe handling practices (Neal et al., 1983; Stellman et el., 1982; Valanis & Brown, 1985) .
Recommendations for safe handling of antineoplastic agents include institution of appropriate engineering controls, use of personal protective equipment, practice of aseptic and hygienic techniques including proper disposal of waste materiels, and education of personnel regarding the nature of safe handling practices for cytotoxic drugs. Most gUldellres include the use of a Class II biological safety cabinet with vertical laminar air floVY, protective gloves and gown and splash goggles during preparation Eating, dnnking, smoking, and storing food in or near the preparation area should be prohibited GUidelines emphasize stnct use of aseptic technique and careful handling of syringes, needles, vials, and ampules In an effort to minimize worker contamination through drug exposure Hands should be washed before and after weanng gloves, and gowns that become contaminated should be changed Immediately Waste materials should be labeled properly, handled separately from other hospital trash, and regarded as hazardous material linen conternmetcd from patient excreta and cytOtOXIC drugs should be specietlv marked and placed In a labeled Impervious container Spills and breakages should be cleaned up Immediately by trained personnel weanng protective apparel and uSing protective equipment All employees with potential exposure to entineoplastk agents, including nurses, pharmacists, physicrens, and housekeeping personnel, should be medically monitored with preplacement and periodic examinations IrlCludlrlg history taking and blood exerrunanon Personnel must recCive mforrnetion on handling procedures, use of protective equipment, and rneteriel disposal SpecliJl wrrtten mstructrons for handling enuneoptasuc c1gents should be available and accessible to all potentially exposed personnel.
SUMMARY
in summary, iJlthough current data have not fully established the hazards or potential carCinogenic risk to health care personnel who handle antineoplastic agents, It IS prudent to recognize that subclinical changes In body chemistry do exrst Long-term health consequences have yet to be determined Recommendations for safe handling of antineoplastic agents must be observed All employees with potentialexposure to antineoplastic agentsnurses, pharmacists, physicians, and housekeeping personnelshould be medically monitored with preplacement and periodic examinations including history taking and blood examination. and practiced by exposed employees In order to minimize untoward health risks. Deadline for applications is January 1, 1987
